Evidence map›Paper›PMID 33494365›Full record

ReviewInternational journal of molecular sciences2021

Racial Disparity in Drug Disposition in the Digestive Tract.

Song Gao, Edward C Bell, Yun Zhang, Dong Liang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Enteral Route Nanomedicine for Cancer Therapy.International journal of nanomedicine · 2024
    Review
  9. Genetic Variation inPharmaceutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Song GaoDepartment of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Edward C BellDepartment of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Yun ZhangDepartment of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Dong LiangDepartment of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Texas Southern University · US

Funding

Targeted Nano-drug-delivery-systems of Frist-in-class Drugs for CRPC: PK/PD Evaluation and Combination TherapyU54MD007605 · NIMHD · TEXAS SOUTHERN UNIVERSITY · PI Dong Liang · 2020 to 2026
$22.0M
Developing Locally Bioavailable Drugs to Inhibit the Aberrantly Elevated PEG2 in the ColonR15GM126475 · NIGMS · TEXAS SOUTHERN UNIVERSITY · PI GAO, SONG · 2018 to 2018
$472k
The Age-Dependence and Cell-Specificity of Breast Cancer Driven by Mutant p53SC2GM135111 · NIGMS · TEXAS SOUTHERN UNIVERSITY · PI ZHANG, YUN · 2020 to 2022
$459k
Cancer Prevention and Research Institute of Texas RP190672 and RP180748NIGMS NIH HHS R15 GM126475NIGMS NIH HHS SC2 GM135111NIH HHS 1R15GM126475-01A1 and 1SC2GM135111-01NIMHD NIH HHS U54 MD007605
6 · The paper itself

Abstract

The major determinants of drug or, al bioavailability are absorption and metabolism in the digestive tract. Genetic variations can cause significant differences in transporter and enzyme protein expression and function. The racial distribution of selected efflux transporter (i.e., Pgp, BCRP, MRP2) and metabolism enzyme (i.e., UGT1A1, UGT1A8) single nucleotide polymorphisms (SNPs) that are highly expressed in the digestive tract are reviewed in this paper with emphasis on the allele frequency and the impact on drug absorption, metabolism, and in vivo drug exposure. Additionally, preclinical and clinical models used to study the impact of transporter/enzyme SNPs on protein expression and function are also reviewed. The results showed that allele frequency of the major drug efflux transporters and the major intestinal metabolic enzymes are highly different in different races, leading to different drug disposition and exposure. The conclusion is that genetic polymorphism is frequently observed in different races and the related protein expression and drug absorption/metabolism function and drug in vivo exposure can be significantly affected, resulting in variations in drug response. Basic research on race-dependent drug absorption/metabolism is expected, and FDA regulations of drug dosing adjustment based on racial disparity are suggested.

Indexed as

Gastrointestinal AbsorptionAllelesAnimalsATP-Binding Cassette TransportersBiological AvailabilityBiological TransportBiomarkersGastrointestinal TractGene FrequencyHumansInactivation, MetabolicMetabolic Clearance RateMicrosomesPolymorphism, Single NucleotideRace FactorsATP-Binding Cassette TransportersBiomarkersdigestive tractdrug dispositionrace

Identifiers

PMID33494365
PMCPMC7865938
OpenAlexW3125644437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.